在癌症幸存者中比较心力衰竭风险评估工具
Cheng Hwee Soh1,2, Thomas H Marwick3,4,5,6
1Imaging Research Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia.
Cardio-oncology (London, England)
|October 11, 2024
概括
在癌症幸存者中,心力衰竭 (HF) 风险计算器HFA-ICOS和ARIC-HF与PCP-HF相比显示出类似的,优异的性能. 建议进一步开发癌症特异性HF预测工具,以改善预防.
科学领域:
- 心脏瘤学 - 心脏瘤学
- 心血管疾病流行病学
- 癌症的生存率 癌症的生存率
背景情况:
- 癌症幸存者面临心力衰竭 (HF) 的高风险,由于共同的风险因素和心脏毒性癌症治疗.
- 有效的HF查依赖于准确的风险评估,但对幸存者的最佳方法仍然不清楚.
- 这项研究比较了癌症幸存者群体中现有的HF风险计算器的性能.
研究的目的:
- 评估和比较三种HF风险计算器在癌症幸存者的预测准确度.
- 确定最有效的风险评估工具来分层这一群体中的HF风险.
- 为癌症幸存者制定有针对性的HF预防策略提供信息.
主要方法:
- 利用英国生物库数据,通过ICD-10代码识别癌症幸存者和非癌症对照.
- 评估使用心力衰竭协会-国际心脏瘤学会 (HFA-ICOS),社区动脉样硬化风险 (ARIC-HF) 和聚合队列方程预防心力衰竭 (PCP-HF) 评分的事件HF风险.
- 使用曲线下的面积 (AUC) 进行预测性能比较,以年龄和性别进行倾向匹配.
主要成果:
- 与PCP-HF (AUC 0.717) 相比,HFA-ICOS (AUC 0.753) 和ARIC-HF (AUC 0.757) 显示出与PCP-HF (AUC 0.717) 相似的和更高的歧视事件HF.
- 所有测试的风险计算器在乳腺癌或淋巴瘤以外的癌症类型的幸存者中表现更好.
- 该研究包括9,232名乳腺癌/淋巴瘤幸存者和23,800名其他癌症类型的幸存者.
结论:
- 在癌症幸存者和对照人群中,HFA-ICOS和ARIC-HF风险计算器在预测癌症幸存者和对照人群中的事件HF方面表现优于PCP-HF.
- 虽然所有模型都显示出适度的歧视,但癌症特异性HF预测工具可以增强预防工作.
- 优化HF风险评估对于癌症幸存者的主动心血管护理至关重要.
相关概念视频
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Comparing the Survival Analysis of Two or More Groups
156
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
156
Heart Failure IV: Classification and Diagnostic Evaluation
2
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
2
Hazard Ratio
91
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
91
Heart Failure V: Nursing Interventions
2
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
2
Heart Failure III: Clinical Manifestations
3
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
3


